BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2633910)

  • 1. Normotensive glucocorticoid-suppressible hyperaldosteronism in adult.
    Maeda T; Ashie T; Kikuiri K; Takakura M; Hikita N; Nakagawa H; Shimamoto K
    Endocrinol Jpn; 1989 Dec; 36(6):817-25. PubMed ID: 2633910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial, dexamethasone-suppressible, normokalemic hyperaldosteronism.
    Grim CE; Weinberger MH
    Pediatrics; 1980 Mar; 65(3):597-604. PubMed ID: 6987607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long term evolution of glucocorticoid-suppressible hyperaldosteronism.
    Stockigt JR; Scoggins BA
    J Clin Endocrinol Metab; 1987 Jan; 64(1):22-6. PubMed ID: 3536983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertension corrected and aldosterone responsiveness to renin-angiotensin restored by long-term dexamethasone in glucocorticoid-suppressible hyperaldosteronism.
    Woodland E; Tunny TJ; Hamlet SM; Gordon RD
    Clin Exp Pharmacol Physiol; 1985; 12(3):245-8. PubMed ID: 2992855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dexamethasone-suppressible hyperaldosteronism. Adrenal transition cell hyperplasia?
    Connell JM; Kenyon CJ; Corrie JE; Fraser R; Watt R; Lever AF
    Hypertension; 1986 Aug; 8(8):669-76. PubMed ID: 3015796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexamethasone-suppressible hyperaldosteronism.
    New MI; Siegal EJ; Peterson RE
    J Clin Endocrinol Metab; 1973 Jul; 37(1):93-100. PubMed ID: 4351777
    [No Abstract]   [Full Text] [Related]  

  • 7. A case of glucocorticoid-suppressible hyperaldosteronism with aldosterone producing adenoma.
    Kato S; Haji M; Yanase T; Nawata H; Kato K; Ibayashi H
    Endocrinol Jpn; 1988 Apr; 35(2):311-20. PubMed ID: 3208706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new family with dexamethasone-suppressible hyperaldosteronism: aldosterone unresponsiveness to angiotensin II.
    Fallo F; Sonino N; Armanini D; Luzzi T; Pedini F; Pasini C; Mantero F
    Clin Endocrinol (Oxf); 1985 Jun; 22(6):777-85. PubMed ID: 2990765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenal glomerulosa function in patients with dexamethasone-suppressible hyperaldosteronism.
    Oberfield SE; Levine LS; Stoner E; Chow D; Rauh W; Greig F; Lee SM; Lightner E; Witte M; New MI
    J Clin Endocrinol Metab; 1981 Jul; 53(1):158-64. PubMed ID: 7016891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticoid-suppressible hyperaldosteronism. Ultrastructural observation of a case.
    Matsuo K; Kawai K; Tsuchiyama H; Ueki Y
    Acta Pathol Jpn; 1985 Nov; 35(6):1511-9. PubMed ID: 3004103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone.
    Sutherland DJ; Ruse JL; Laidlaw JC
    Can Med Assoc J; 1966 Nov; 95(22):1109-19. PubMed ID: 4288576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dexamethasone suppressible hyperaldosteronism in a child with nephrosclerosis.
    Lee SM; Lightner E; Witte M; Oberfield S; Levine L; New MI
    Acta Endocrinol (Copenh); 1982 Feb; 99(2):251-5. PubMed ID: 6277130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circadian rhythm of plasma aldosterone concentration in patients with primary aldosteronism.
    Kem DC; Weinberger MH; Gomez-Sanchez C; Kramer NJ; Lerman R; Furuyama S; Nugent CA
    J Clin Invest; 1973 Sep; 52(9):2272-7. PubMed ID: 4353776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mineralocorticoid and metabolic response to metyrapone on normotensive children and children with dexamethasone-suppressible and primary hyperaldosteronism.
    Sonino N; Levine LS; New MI
    Acta Endocrinol (Copenh); 1981 Sep; 98(1):87-94. PubMed ID: 7025545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary aldosteronism due to unilateral adrenal hyperplasia.
    Ganguly A; Zager PG; Luetscher JA
    J Clin Endocrinol Metab; 1980 Nov; 51(5):1190-4. PubMed ID: 6252233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary hyperaldosteronism in childhood due to unilateral macronodular hyperplasia. Case report.
    Oberfield SE; Levine LS; Firpo A; Lawrence D; Stoner E; Levy DJ; Sen S; New MI
    Hypertension; 1984; 6(1):75-84. PubMed ID: 6319281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of naloxone on the pituitary-adrenal axis in patients with dexamethasone-suppressible hyperaldosteronism.
    Fallo F; Boscaro M; Sonino N; Mantero F
    Clin Endocrinol (Oxf); 1987 Feb; 26(2):163-8. PubMed ID: 2822294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical evidence of aldosterone overproduction and abnormal regulation in normotensive individuals with familial hyperaldosteronism type I.
    Stowasser M; Huggard PR; Rossetti TR; Bachmann AW; Gordon RD
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4031-6. PubMed ID: 10566645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Unilateral autonomous aldosterone production in hyperaldosteronism suppressible by dexamethasone].
    Jakob F; Seufert J; Haack D; Schröder K; Ludwig J; Rendl J; Vecsei P
    Dtsch Med Wochenschr; 1993 Dec; 118(50):1837-43. PubMed ID: 8269828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertension corrected by discontinuing chronic sodium bicarbonate ingestion. Subsequent transient hypoaldosteronism.
    Lowder SC; Brown RD
    Am J Med; 1975 Feb; 58(2):272-9. PubMed ID: 1115072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.